KEMPEN and CO U.S.A. Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • KEMPEN and CO U.S.A.'s estimated annual revenue is currently $35M per year.(i)
  • KEMPEN and CO U.S.A.'s estimated revenue per employee is $124,113

Employee Data

  • KEMPEN and CO U.S.A. has 282 Employees.(i)
  • KEMPEN and CO U.S.A. grew their employee count by -10% last year.

KEMPEN and CO U.S.A.'s People

NameTitleEmail/Phone
1
Head European Real EstateReveal Email/Phone
2
Executive DirectorReveal Email/Phone
3
Senior Operational Services / Agency ServicesReveal Email/Phone
4
Healthcare Investment Banking AnalystReveal Email/Phone
5
Equity Research AnalystReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$75M2750%N/AN/A
#2
$35M74-7%N/AN/A
#3
$75M4183%N/AN/A
#4
$7.5M7-22%N/AN/A
#5
N/A20-9%N/AN/A
#6
$9070M5864N/AN/AN/A
#7
$7.5M5522%N/AN/A
#8
$15M154N/AN/AN/A
#9
$35M644-21%N/AN/A
#10
$35M48-8%N/AN/A
Add Company

What Is KEMPEN and CO U.S.A.?

Categorized under Financial Advisory Services. Current estimates show this company has an annual revenue of $2.5 to 5 million and employs a staff of approximately 5 to 9.

keywords:N/A

N/A

Total Funding

282

Number of Employees

$35M

Revenue (est)

-10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

KEMPEN and CO U.S.A. News

2022-04-17 - Kempen excludes Brazil from new sustainable EM index

Fiduciary manager Van Lanschot Kempen has developed a new sustainable emerging markets index for its pension fund clients.

2022-04-17 - Medivir to participate at the Kempen Life Sciences Conference

STOCKHOLM, Sweden, April 19, 2022 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will participate at...

2022-04-17 - Van Lanschot Kempen: update on share buy-back programme ...

Amsterdam/'s-Hertogenbosch, the Netherlands, 19 April 2022. In the period from 12 April 2022 until 18 April 2022 Van Lanschot Kempen has...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$39.4M282-2%$161.4M
#2
$83.8M28210%N/A
#3
$15M282-3%N/A
#4
$45M282-14%N/A
#5
$43.4M282N/AN/A